In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.
We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.
Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.
Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.
Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.
This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.
This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.
This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.
SAMU provides strategic, clinical and implementation support to various MSF projects with medical activities related to HIV and TB. This medical unit is based in Cape Town, South Africa.
BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.
Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.
Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.
Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.
The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.
The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.
The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.
A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.
We are working with the Tajikistan Ministry of Health to diagnose and treat children, and their family members who are diagnosed with drug-sensitive and drug-resistant tuberculosis (DR-TB).
Where possible, we aim to treat TB patients at home, and demonstrate that comprehensive TB care for children is feasible. We also support the paediatric TB hospital in Dushanbe and the paediatric ward in Machiton hospital.
The comprehensive model of TB care includes patient follow-up, active testing for new patients, laboratory diagnosis, individualised treatment and psychosocial support (including play therapy).
The project also treats children who have both TB and HIV, and TB and severe malnutrition.
In the south of the country, we run the Kulob paediatric HIV and family project. The main objective is to reduce illness and mortality of children with HIV/AIDS, with a special focus on co-infections with other diseases and the prevention of HIV transmission.
In 2018
220
22
people started on treatment for TB
110
11
people started on treatment for MDR-TB
190
19
people treated for HIV
Tuberculosis
Breaking the cycle: Paediatric DR-TB detection, care and treatment in Tajikistan
Report17 May 2019
Tajikistan
Stories from MSF's paediatric TB projects
Project Update4 Nov 2016
Global
Shorter TB regimens offer new hope
Opinion12 May 2016
Tajikistan
Children with tuberculosis must not be neglected
Project Update17 Dec 2013
Tuberculosis
Improving paediatric TB care in Tajikistan
Report17 Dec 2013
Tajikistan
MSF treats youngest ever MDR-TB patient
Project Update12 Mar 2013
1997
1997
Year MSF first worked in the country
Related topics
Medical Activities
Tuberculosis
Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.5 million people in 2018, TB is the world’s deadliest infectious disease (WHO).
Medical Activities
HIV/AIDS
Nearly 800,000 people die each year from HIV/AIDS, while nearly 2 million people become newly infected with the virus.
